LVW Advisors LLC Acquires 1,381 Shares of HCA Healthcare, Inc. (NYSE:HCA)

LVW Advisors LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 76.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,189 shares of the company’s stock after acquiring an additional 1,381 shares during the quarter. LVW Advisors LLC’s holdings in HCA Healthcare were worth $1,064,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Stone House Investment Management LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at $25,000. Centerpoint Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $27,000. Bruce G. Allen Investments LLC bought a new position in HCA Healthcare in the fourth quarter valued at approximately $28,000. Finally, Northwest Investment Counselors LLC bought a new position in shares of HCA Healthcare in the 1st quarter worth $36,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HCA. Wells Fargo & Company boosted their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Robert W. Baird started coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. TD Cowen lowered their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada lifted their price objective on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $326.53.

HCA Healthcare Price Performance

Shares of HCA opened at $321.28 on Monday. The company’s fifty day simple moving average is $325.96 and its 200 day simple moving average is $317.82. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $344.20. The company has a market cap of $84.15 billion, a price-to-earnings ratio of 16.02, a PEG ratio of 1.49 and a beta of 1.68. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the prior year, the business earned $4.93 EPS. The firm’s revenue for the quarter was up 11.2% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend was Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock worth $3,921,929 in the last ninety days. 1.70% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.